Anti-tissue Transglutaminase IgG (Maglumi Anti-tissue Transglutaminase IgG ) - India CDSCO Medical Device Registration

Anti-tissue Transglutaminase IgG (Maglumi Anti-tissue Transglutaminase IgG ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000151_c1ab1a576bfcb48dfecc1528320940b7_a0b8b4d810034c47bc5ba6aa0a2b1f13. This device is marketed under the brand name CLIA. The license holder is Medispace Solutions, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.